Long-Term Outcomes with Sotorasib in KRAS G12cMutated Advanced NSCLC from the Global Expanded Access Program (EAP) Study-436

被引：0

作者：

Novello, S. ^{[1
]}

Maimon, N. ^{[2
]}

Stevenson, J. ^{[3
]}

Petty, W. ^{[4
]}

Ferreira, C. G. ^{[5
]}

Morbeck, I. ^{[5
]}

Zer, A. ^{[6
]}

Bauman, J. ^{[7
]}

Kalmadi, S. ^{[8
]}

Xia, C. ^{[9
]}

Meloni, A. R. ^{[9
]}

Mehta, B. ^{[9
]}

Ardito-Abraham, C. ^{[9
]}

Kormany, W. ^{[9
]}

Awad, M. ^{[10
]}

机构：

[1] Univ Turin, AOU San Luigi, Orbassano, TO, Italy

[2] Sackler Sch Med, Div Oncol, Meir Med Ctr, LungOncol Serv, Rishon Leziyyon, Israel

[3] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[4] Wake Forest Univ, Sch Med, Winston Salem, NC 27101 USA

[5] Oncoclinicas & CO, Med Sci Innovat Res MedSir, Sao Paulo, Brazil

[6] Rabin Med Ctr, Davidoff Canc Ctr, Petah Tiqwa, Israel

[7] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[8] Ironwood Canc & Res Ctr, Chandler, AZ USA

[9] Amgen Inc, Thousand Oaks, CA USA

[10] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.12E.04

引用

页码：S352 / S353

页数：2

共 23 条